Upload
others
View
5
Download
0
Embed Size (px)
Citation preview
2019 MICNP Conference 3/23/2019
1
An Evidence-Based Algorithm for Deprescribing
Diabetes Medications
Caroline Trapp, DNP, ANP-BC, CDE, FAANP, DiplomateACLM
Director of Diabetes Education and Care
Physicians Committee for Responsible Medicine
Washington, DC
Disclosure of Financial Conflicts of Interest for Caroline Trapp
• None
• Nada
• Zip
• Zero
• Not a bit
• Not an iota
• Not a hint
1
2
2019 MICNP Conference 3/23/2019
2
Objectives
1. Describe the risks of antihyperglycemicmedication use in elderly patients with type 2 diabetes.
2. Discuss appropriate use of an algorithm to safety deprescribe certain medications.
NPs and Rxs – A reasonable effort to prevent complications of T2DM
3
4
2019 MICNP Conference 3/23/2019
3
What 3 classes of medications for T2DM can cause hypoglycemia?
• Insulin
• Sulfonylureas
• Meglitinides
Hypoglycemia
5
6
2019 MICNP Conference 3/23/2019
4
Severe Hypoglycemia - 20191
• Impaired cognition and physical function
• Depression and reduced quality of life
• Confusion, delirium
• Loss of consciousness
• Seizure
• Coma
• Falls
• MVI or other injury
• ER visits and hospitalizations
• Major cardiovascular events (within 3 months – VADT)2
• Death1. ADA Diabetes Care 2019;42(Suppl.1)S61-702. Davis SN et al. Diabetes Care 2018; doi:10.2337/dc18-1144
Repeated episodes of hypoglycemia:
• Hypoglycemia Unawareness
• Dementia
ADA Diabetes Care 2019;42(Suppl.1)S61-70
7
8
2019 MICNP Conference 3/23/2019
5
• Serious hypoglycemia: a national public health issue.1-2
• Defined as requiring third-party assistance.3
• Any reading <70 mg/dL may have clinical implications due to hypoglycemic unawareness.3
1. Tseng C-L, et al. JAMA Intern Med. 20142. Pogach L & Aron D. JAMA. 2010;303(20):2076-20773. ADA Diabetes Care 2019;42(Suppl.1)S61-70.
Morbidity
Mortality
Finding Balance
From Overtreatment
Prevent DM Complications
9
10
2019 MICNP Conference 3/23/2019
6
Tight control – the holy grail of diabetes management
Factors to consider with A1c target
• Age
• Life expectancy
• Comorbid conditions
• Duration of diabetes
• Risk of hypoglycemia
• Motivation and adherence
• Quality of life
• Patient satisfaction
11
12
2019 MICNP Conference 3/23/2019
7
Approach to the Management of Hyperglycemia
low high
newly diagnosed long-standing
long short
absent severeFew/mild
absent severeFew/mild
highly motivated, adherent, excellent self-care capabilities
readily available limited
less motivated, nonadherent, poor self-care capabilities
A1C7%
more stringent
less stringent
Patient/Disease Features
Risks associated with hypoglycemia& other drug adverse effects
Disease Duration
Life expectancy
Important comorbidities
Established vascular complications
Patient attitude & expected treatment efforts
Resources & support system
American Diabetes Association Standards of Medical Care in Diabetes. Glycemic targets. Diabetes Care 2016; 39 (Suppl. 1): S39-S46
Choosing Wisely
Avoid using all medications other than metformin to achieve A1c <7.5% in most older adults; moderate control is generally better.
Among non-older adults, …using medications to achieve (A1c < 7% is associated with harms, including higher mortality rates.
American Geriatrics SocietyFeb. 21, 2013; revised April 23, 2015ChoosingWisely.org
13
14
2019 MICNP Conference 3/23/2019
8
New Guidelines! March 6, 2018, American College of Physicians
Qaseem et al. Ann Intern Med.2018;168:569-576.
15
16
2019 MICNP Conference 3/23/2019
9
American College of Physicians• Five large-scale international trials.
• Problems with major guidelines.
• Evidence does not support using medications to aggressively lower A1c for most patients.
• Greater use of lifestyle interventions – A1c reduction with lifestyle is SAFE! And Effective!
– #1: Discuss benefits and harms, individualize care.
– #2: A1c range of 7-8% for most patients.
– #3: No target A1c for frail elderly: treat symptoms only.
Not without controversy…
17
18
2019 MICNP Conference 3/23/2019
10
There is agreement re: need to use less in older adults.
How?
Deprescribing.org
19
20
2019 MICNP Conference 3/23/2019
11
21
22
2019 MICNP Conference 3/23/2019
12
Besides hypoglycemia, are there other reasons to
deprescribe?
Polypharmacy
29.4% of elderly patients have been prescribed 6 or more concurrent drugs.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2546482/
23
24
2019 MICNP Conference 3/23/2019
13
COST
Over the past 11 years, insulin prices have increased 197%.
Herman et al. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886177http://care.diabetesjournals.org/content/42/Supplement_1/S90
The Miracle of Insulin
25
26
2019 MICNP Conference 3/23/2019
14
Unforseen Risks of Specific Medications
Consider:Troglitizone – Off the market 2000Insulin inhalation – Off the market 2007Exenatide and sitagliptin –concerns re: pancreatitisRosiglitazone – FDA restricted access due to cardiovascular risks May 2011Pioglitazone – FDA linked to bladder cancer June 2011
Cartoon by permission of Dan Piraro, creator of Bizarro, Bizarro.com
Opportunity Costs vs. Gains
Costs:
• John Abrahamson, MD: “A prescription is a missed opportunity to empower the patient to change lifestyle.”
Gains:
• Lifestyle changes get at the underlying problem(s).
27
28
2019 MICNP Conference 3/23/2019
15
Meet Debbie, RNA1c 6.6%
2013
Circulation. 2017;135:180-195. DOI: 10.1161/CIRCULATIONaha.116.022622.
29
30
2019 MICNP Conference 3/23/2019
16
“Glycemic control [with medication] had no effect on mortality or clinically relevant complications.”
Makam & Nguyen. Circulation. 2017;135:180-195. DOI: 10.1161/CIRCULATIONaha.116.022622
31
32
2019 MICNP Conference 3/23/2019
17
The reported benefits of tight control (UKPDS)
Retinopathy
Neuropathy
Nephropathy
Nonfatal MI
29% ↓ per 0.9% A1c drop
19% ↓ ‘’ ‘’
33% ↓ ‘’ ‘’
15% ↓ per 1% A1c drop
Makam, AN & Nguyen OK. Circulation.2017;135:180-195. DOI:10:1161/CIRCULATIONAHA.116.022622
What outcomes were studied?
Outcomes
Retinopathy
Neuropathy
Nephropathy
Nonfatal MI
Risk Reduction
29% ↓ per 0.9% A1c drop
19% ↓ ‘’ ‘’
33% ↓ ‘’ ‘’
15% ↓ per 1% A1c drop
Circulation.2017;135:180-195. DOI:10:1161/CIRCULATIONAHA.116.022622
Reported Outcomes: Surrogate, not Meaningful• Progression of retinopathy on exam, vs. loss of vision• Loss of reflexes or sensation, vs. symptomatic neuropathy or
amputation• Microalbuminuria vs. kidney failure requiring dialysis• Non-fatal MI vs. stroke or death from CV disease
33
34
2019 MICNP Conference 3/23/2019
18
Can you spot the surrogate marker?
35
36
2019 MICNP Conference 3/23/2019
19
% drop, compared to what?
Outcomes
Retinopathy
Neuropathy
Nephropathy
Nonfatal MI
Relative Risk
Reduction
29% ↓ per 0.9% A1c drop
19% ↓ ‘’ ‘’
33% ↓ ‘’ ‘’
15% ↓ per 1% A1c drop
Circulation.2017;135:180-195. DOI:10:1161/CIRCULATIONAHA.116.022622
ADVANCE Study: Benefit of intensive control
NEPHROPATHY
20% relative risk reduction; 1.1% absolute risk reduction
• 4.1% (intensive control)
• 5.2% (standard treatment)
1 in 100 people in 5 years did not
develop nephropathy
37
38
2019 MICNP Conference 3/23/2019
20
Figure 6. Conceptual model for classifying hemoglobin A1c distribution among US adults with diabetes, NHANES, 2011-2012
Makam & Nguyem. Circulation. 2017;135:180-195. DOI: 10.1161/CIRCULATIONaha.116.022622.
Erlich DR, Slawson DC, Shaughnessy AF. Am Fam Phys 2014;89(4):257-258
Lending a Hand to Patient with Type 2 Diabetes: A Simple Way to Communicate Treatment Goals
39
40
2019 MICNP Conference 3/23/2019
21
How do we best advise patients when:
• Guidelines for clinical targets are not in agreement.
• We are exhorted to aggressively use medications to fix “uncontrolled” diabetes.
• Quality measures look at intermediate measures (e.g. A1c); prevention of hypoglycemia or other adverse outcome(s) are usually not measured.
Evidence-based medicine framework for clinical decision making. a Estimated on the basis of age, comorbidities, and functional status. b Includes an individual’s lifestyle, social support,
financial circumstances, and workload capacity.
Anil N. Makam, and Oanh K. Nguyen Circulation. 2017;135:180-195
Copyright © American Heart Association, Inc. All rights reserved.
41
42
2019 MICNP Conference 3/23/2019
22
STEPS Mnemonic
1. How safe is the drug for various patient populations?
2. Is the drug well tolerated or do its adverse effects cause patients to stop taking it?
3. Has the drug been shown to be effectivefor various patient populations?
4. How will the price of the drug affect adherence?
5. Will addition of this drug be simple or difficult for various patient populations?
Management of Hyperglycemia in T2DMADA, 2018
43
44
2019 MICNP Conference 3/23/2019
23
Glucose-lowering medication in type 2 diabetes: overall approach.
American Diabetes Association Diabetes Care 2019;42:S90-S102
©2019 by American Diabetes Association
2019
How not to choose
45
46
2019 MICNP Conference 3/23/2019
24
47
48
2019 MICNP Conference 3/23/2019
25
Medication Sample Closet and Refrigerator
If all you have is a hammer, everything looks like a nail.
49
50
2019 MICNP Conference 3/23/2019
26
K.I.S.S.*
Keep It Simple, Sister!
Lifestyle
Safest Intervention?
Medications
51
52
2019 MICNP Conference 3/23/2019
27
Treat the Cause
Deprescribing medications, while prescribing evidence-based lifestyle intervention(s), may lead to prevention or remission of type 2 diabetes.
Plant-Based Dietary Pattern
• Whole grains
• Vegetables
• Beans, Peas, Lentils
• Fruit
• Water (not cow’s milk)
• Small amounts of nuts and seeds
• Vitamin B12
The Power Plate – Physicians Committee for Responsible Medicine
53
54
2019 MICNP Conference 3/23/2019
28
Debbie, RN, 2017
A plant-based dietary pattern is recommended by:
• American Association of Clinical Endocrinologists (2018)
• American Diabetes Association (2010-2019)
• Canadian Diabetes Association
• Canada Food Guide (2019)
• Dietary guidelines of Sweden, Brazil, Germany, Qatar, the Netherlands, Denmark, Finland, Iceland, Norway & Sweden
• USDA Dietary Guidelines Advisory Committee (2015)
• American Institute for Cancer Research (2009)
55
56
2019 MICNP Conference 3/23/2019
29
Acceptability
A Plant-Based Diet has been found to be highly acceptable in diverse populations with various disease states.
Trapp C, Barnard ND, et al. A plant-based diet for type 2 diabetes: scientific support and practical strategies. Diabetes Educ. 2010;36:33-48.
Plant-Based Dietary Pattern: Significant Benefits
Beyond Diabetes*
• Acne
• Appendicitis
• Arthritis
• Atherosclerosis (CMS, 2014)
• Cancer (WHO, 2015)
• Constipation
• Erectile Dysfunction
• High Cholesterol
• Hypertension
• Irritable Bowel Disease
• Multiple Sclerosis
• Osteoporosis
• Renal Insufficiency/CKD
• Stroke
• Weight Control
*More information: NutritionMD.org and NutritionFacts.org
57
58
2019 MICNP Conference 3/23/2019
30
https://www-ncbi-nlm-nih-gov.proxy.lib.umich.edu/pubmed/29659968
Easy. Delicious! Affordable.
59
60
2019 MICNP Conference 3/23/2019
31
“Cross Titrate*”Up-prescribe Plants
1. Assess interest.
2. Assess diet (typical meals, likes and dislikes, etc.)
3. Basic instruction (plan some meals)
4. Resources (Pt and Family)
5. Referrals
De-prescribe Meds1. Identify medications that
can become too strong with diet change.
2. Identify medications that patient would most like to discontinue.
3. Discuss known benefits and risks, establish priorities, and document discussion.
4. Determine targets for BP, lipids, A1c/glucose.
5. Schedule follow ups. * Term from Michelle McMaken, MD
Special Considerations
• Hypoglycemia: Patients on insulin or sulphonylureas
• Hypotension
• Anticoagulants (warfarin)
• Add Vitamin B12 (recommended with plant-baseddiet, and/or over the age of 50, and/or metformin)
61
62
2019 MICNP Conference 3/23/2019
32
What to do with those de-prescribed drugs?
Do Not Flush!!!
Find a local program: search “drug disposal/takeback.”Last resort: mix with wet cat litter or used coffee grounds and put in sealed container in trash.
Summary – Type 2 Diabetes• Prevention of hypoglycemia is a greater priority than tight control,
especially in elderly patients.
• Patients on SFUs, meglitinides or insulin should be regularly assessed for reduction or discontinuation (see deprescribing.org). Hypoglycemia s&s, prev. and tx should be regularly reviewed.
• Medication might be reserved for patients who are symptomatic and unwilling or unable to make lifestyle changes.
• A plant-based dietary pattern over any medication offers benefits beyond glycemic control and is a safe, affordable and an acceptable option that may be offered to all patients.
• Nurse practitioners should resist calls to intensify treatment, in favor of patient-centered care and shared decision making.
63
64
2019 MICNP Conference 3/23/2019
33
Resources
65
66
2019 MICNP Conference 3/23/2019
34
21-Day Vegan Kickstart (Free!)
21DayKickstart.org
App Website
https://nutritionguide.pcrm.org
67
68
2019 MICNP Conference 3/23/2019
35
Coding/Billing• E & M Codes (99212-99215)
(document: “>50% of time spent on counseling & education”)
• ICD-10 Codes
– Type 2 Diabetes (e.g.E11.65 w/hyperglycemia)
Plus Z codes (help to explain the time spent)
– Dietary counseling and surveillance Z71.3
– Inappropriate diet and eating habits Z72.4
– Long Term Insulin Use Z79.4
PreventionOfDisease.org
Sat. May 18 – Mon. May 20, 2019
69
70
2019 MICNP Conference 3/23/2019
36
July 25-27, 2019
Be a joyful NP!
71
72
2019 MICNP Conference 3/23/2019
37
Cartoon used with permission of Dan Piraro
73